Prognostic significance of baseline C-reactive protein/albumin ratio for long-term outcomes in advanced gastric cancer under immunochemotherapy

doi:10.4251/wjgo.v18.i6.117582

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 6

This Article

(18)

(24)

(0)

(27)

(778)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117582
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117582

Table 2 Tumor responses stratified by C-reactive protein to albumin ratio (< 0.21 vs ≥ 0.21), n (%)

Variables	Total (n = 200)	High (n = 80)	Low (n = 120)	Statistic	P value
CR
No	189 (94.50)	76 (95.00)	113 (94.17)
Yes	11 (5.50)	4 (5.00)	7 (5.83)
PR
No	104 (52.00)	48 (60.00)	56 (46.67)
Yes	96 (48.00)	32 (40.00)	64 (53.33)
SD
No	159 (79.50)	63 (78.75)	96 (80.00)
Yes	41 (20.50)	17 (21.25)	24 (20.00)
PD
No	148 (74.00)	53 (66.25)	95 (79.17)
Yes	52 (26.00)	27 (33.75)	25 (20.83)
ORR				χ² = 3.87	0.049
No	93 (46.50)	44 (55.00)	49 (40.83)
Yes	107 (53.50)	36 (45.00)	71 (59.17)
DCR				χ² = 4.16	0.041
No	52 (26.00)	27 (33.75)	25 (20.83)
Yes	148 (74.00)	53 (66.25)	95 (79.17)

CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; ORR: Objective response rate; DCR: Disease control rate.

Full Size Table

Citation: Mei S, Ye ML, Hao QL, Li GC, Yao ZY, Wang HY. Prognostic significance of baseline C-reactive protein/albumin ratio for long-term outcomes in advanced gastric cancer under immunochemotherapy. World J Gastrointest Oncol 2026; 18(6): 117582
URL: https://www.wjgnet.com/1948-5204/full/v18/i6/117582.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.117582

Mei S, Ye ML, Hao QL, Li GC, Yao ZY, Wang HY. Prognostic significance of baseline C-reactive protein/albumin ratio for long-term outcomes in advanced gastric cancer under immunochemotherapy. World J Gastrointest Oncol 2026; 18(6): 117582 [DOI: 10.4251/wjgo.v18.i6.117582]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.